Researchers from Fudan University Describe Findings in Cancer Imaging (Preliminary Study of a Novel Fap-targeted Ligand ⁶⁸ga-dota-fl In Colon Cancer Imaging Using Small-animal Pet/ct).

Researchers from Fudan University in Shanghai, China have conducted a preliminary study on a novel fibroblast activation protein (FAP)-targeted ligand for colon cancer imaging. The study used small-animal PET/CT imaging to examine the feasibility of a gallium-68-labeled FAP-targeted ligand for tumor imaging. The results showed that the ligand can be used for specific tumor imaging in mouse models, providing a potential alternative for FAP-targeted tumor imaging. The research was supported by the National Natural Science Foundation of China and the Shanghai Sailing Program. [Extracted from the article]

Copyright of Clinical Oncology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)